GalassiA., BellasiA., AuricchioS., PapagniS., CozzolinoM.. Which vitamin D in CKD-MBD? The time of burning questions.Biomed Res Int2013; 2013: 864012.
2.
DussoA., ArcidiaconoM.V.. La carbamazepina antagonizza la soppressione di vitamina D-mediata dell'iperparatiroidismo secondario: patogenesi e possibilità terapeutiche.Giornale di Techniche Nefrologiche e Dialitiche2014; 26(4): 354–8.
3.
Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group.KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD).Kidney Int Suppl2009; (113): S1–130.
